WELLS FARGO & COMPANY/MN - SONNET BIOTHERAPEUTC HLDNG I ownership

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 1 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q2 2022$0379
+8.6%
0.00%
Q1 2022$0349
+4.2%
0.00%
Q4 2021$0335
+134.3%
0.00%
Q3 2021$0143
+180.4%
0.00%
Q2 2021$051
+88.9%
0.00%
Q1 2021$027
+575.0%
0.00%
Q4 2020$040.0%0.00%
Q3 2020$040.0%0.00%
Q2 2020$040.00%
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q3 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 255,434$106,0000.01%
TWO SIGMA SECURITIES, LLC 32,059$13,0000.00%
Advisory Services Network, LLC 50,525$21,0000.00%
Main Street Financial Solutions, LLC 10,657$4,0000.00%
UBS Group AG 45,888$19,0000.00%
IFP Advisors, Inc 2,000$1,0000.00%
BANK OF AMERICA CORP /DE/ 38$00.00%
WELLS FARGO & COMPANY/MN 335$00.00%
NORTHERN TRUST CORP 43,615$18,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders